The Biological Effects of Concentrated Growth Factors on the Differentiation and Proliferation of Human Gingival Fibroblasts
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The aim of this study was to elucidate the effects of concentrated growth factors (CGFs) on human gingival fibroblasts in vitro. Blood was collected from three male volunteers (average age 27 years). CGFs were prepared using standard protocols. The CGF exudates were collected at the following culture time points: 1, 7, 14, and 21 days. The levels of platelet-derived growth factor BB (PDGF-BB) and transforming growth factor β1 (TGF-β1) in CGFs were quantified. The CGF exudates were then used to culture human gingival fibroblasts. The biologic characteristics of these fibroblasts were analyzed in vitro for 21 days. Platelet-rich plasma released the highest amounts of TGF-β1 and PDGF-BB on the first day. The level of TGF-β1 had decreased slightly by day 7, although the difference compared to levels at day 1 was not statistically significant. However, by days 14 and 21, levels of TGF-β1 had dropped significantly compared to day 1 levels. The levels of PDGF-BB at days 7, 14, and 21 did not differ significantly from that measured on day 1. CGFs maintained the release of autologous growth factors for a reasonable period of time (7 days for TGF-β1 and 21 days for PDGF-BB). Gingival fibroblasts treated with CGF exudates collected at day 14 reached peak viability and synthesized type I collagen. Furthermore, the CGF exudates exerted positive effects on the proliferation and differentiation of these cells at days 1, 7, 14, and 21. The findings of this study suggest that treatment with CGFs represents a promising method of enhancing mucosal healing following surgical procedures.
Abstract
The aim of this study was to elucidate the effects of concentrated growth factors (CGFs) on human gingival fibroblasts in vitro. Blood was collected from three male volunteers (average age 27 years). CGFs were prepared using standard protocols. The CGF exudates were collected at the following culture time points: 1, 7, 14, and 21 days. The levels of platelet-derived growth factor BB (PDGF-BB) and transforming growth factor β1 (TGF-β1) in CGFs were quantified. The CGF exudates were then used to culture human gingival fibroblasts. The biologic characteristics of these fibroblasts were analyzed in vitro for 21 days. Platelet-rich plasma released the highest amounts of TGF-β1 and PDGF-BB on the first day. The level of TGF-β1 had decreased slightly by day 7, although the difference compared to levels at day 1 was not statistically significant. However, by days 14 and 21, levels of TGF-β1 had dropped significantly compared to day 1 levels. The levels of PDGF-BB at days 7, 14, and 21 did not differ significantly from that measured on day 1. CGFs maintained the release of autologous growth factors for a reasonable period of time (7 days for TGF-β1 and 21 days for PDGF-BB). Gingival fibroblasts treated with CGF exudates collected at day 14 reached peak viability and synthesized type I collagen. Furthermore, the CGF exudates exerted positive effects on the proliferation and differentiation of these cells at days 1, 7, 14, and 21. The findings of this study suggest that treatment with CGFs represents a promising method of enhancing mucosal healing following surgical procedures.
참고문헌 (23)
- Chiapasco M, "Clinical outcomes of GBR procedures to correct peri-implant dehiscences and fenestrations: a systematic review", Clin Oral Implants Res, 20, pp.113~123 (2009)
- Nkenke E, "Clinical outcomes of sinus floor augmentation for implant placement using autogenous bone or bone substitutes: a systematic review", Clin Oral Implants Res, 20, pp.124~133 (2009)
- Haney JM, "Periodontal repair in dogs: expanded polytetrafluoroethylene barrier membranes support wound stabilization and enhance bone regeneration", J Periodontol, 64, pp.883~890 (1993)
- Wang HL, "“PASS” principles for predictable bone regeneration", Implant Dent, 15, pp.8~17 (2006)
- Simonpieri A, "The Relevance of Choukroun’s platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implant surgery, prosthodontics, and survival", Implant Dent, 18, pp.220~229 (2009)
- Gonshor A, "Technique for producing platelet-rich plasma and platelet concentrate: background and process", Int J Periodontics Restorative Dent, 22, pp.547~557 (2002)
- Marx RE, "The sinus bone graft", pp.183~189 (1999), Quintessence
- Wang HL, "Platelet rich plasma: myth or reality", Eur J Dent, 1, pp.192~194 (2007)
- Sánchez AR, "Is platelet-rich plasma the perfect enhancement factor? A current review", Int J Oral Maxillofac Implants, 18, pp.93~103 (2003)
- Landesberg R, "Risks of using platelet rich plasma gel", J Oral Maxillofac Surg, 56, pp.1116~1117 (2003)
- Dohan DM, "Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part II: platelet-related biologic features", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, pp.45~50 (2006)
- Mosesson MW, "The structure and biological features of fibrinogen and fibrin", Ann N Y Acad Sci, 936, pp.11~30 (2001)
- Clark RA, "Fibrin and wound healing", Ann N Y Acad Sci, 936, pp.355~367 (2001)
- Collen A, "Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells", Angiogenesis, 2, pp.153~165 (1998)
- Van Hinsbergh VW, "Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells", Ann N Y Acad Sci, 936, pp.426~437 (2001)
- Sacco L, "Lecture" (2006), International academy of implant prosthesis and osteoconnection
- Marx RE, "Platelet-rich plasma: growth factor enhancement for bone grafts", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85, pp.638~646 (1998)
- Kiuru J, "Cytoskeleton-dependent release of human platelet epidermal growth factor", Life Sci, 49, pp.1997~2003 (1991)
- Sunitha Raja V, "Platelet-rich fibrin: evolution of a second-generation platelet concentrate", Indian J Dent Res, 19, pp.42~46 (2008)
- Su CY, "In vitro release of growth factors from applications of PRF", Oral Sur Oral Med Oral Pathol Oral Radiol Endod, 108, pp.56~61 (2009)
- Gassling VL, "Platelet-rich Plasma and Platelet-rich fibrin in human cell culture", Oral Sur Oral Med Oral Pathol Oral Radiol Endod, 108, pp.48~55 (2009)
- He L, "A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, pp.707~713 (2009)
- Ivarsson M, "Type I collagen synthesis in cultured human fibroblasts: regulation by cell spreading, platelet-derived growth factor and interactions with collagen fibers", Matrix Biol, 16, pp.409~425 (1998)